209 related articles for article (PubMed ID: 22100514)
21. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
Li H; Kiang YH; Jona J
Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
[TBL] [Abstract][Full Text] [Related]
22. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
[TBL] [Abstract][Full Text] [Related]
23. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
Sher P; Ingavle G; Ponrathnam S; Pawar AP
Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
[TBL] [Abstract][Full Text] [Related]
24. Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim.
Caira MR; Bettinetti G; Sorrenti M; Catenacci L
J Pharm Sci; 2007 May; 96(5):996-1007. PubMed ID: 17455357
[TBL] [Abstract][Full Text] [Related]
25. Preparation of a solid dispersion of felodipine using a solvent wetting method.
Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
[TBL] [Abstract][Full Text] [Related]
26. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
27. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
[TBL] [Abstract][Full Text] [Related]
28. Crystal forms of SK-3530.
Song HO; Sohn YT
Arch Pharm Res; 2010 Dec; 33(12):2033-6. PubMed ID: 21191770
[TBL] [Abstract][Full Text] [Related]
29. Polymorphic properties and dissolution profile of efavirenz due to solvents recrystallization.
Wardhana YW; Soewandhi SN; Wikarsa S; Suendo V
Pak J Pharm Sci; 2019 May; 32(3):981-986. PubMed ID: 31278710
[TBL] [Abstract][Full Text] [Related]
30. Crystal forms of tolbutamide from acetonitrile and 1-octanol: effect of solvent, humidity and compression pressure.
Chakravarty P; Alexander KS; Riga AT; Chatterjee K
Int J Pharm; 2005 Jan; 288(2):335-48. PubMed ID: 15620874
[TBL] [Abstract][Full Text] [Related]
31. Preparation and evaluation of metastable solid-state forms of lopinavir.
Lemmer HJ; Liebenberg W
Pharmazie; 2013 May; 68(5):327-32. PubMed ID: 23802429
[TBL] [Abstract][Full Text] [Related]
32. Characterization of polymorphic ampicillin forms.
Baraldi C; Tinti A; Ottani S; Gamberini MC
J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
[TBL] [Abstract][Full Text] [Related]
33. Solid-state study of mepivacaine hydrochloride.
Giannellini V; Bambagiotti-Alberti M; Bartolucci G; Bruni B; Coran SA; Costantino F; Di Vaira M
J Pharm Biomed Anal; 2005 Sep; 39(3-4):444-54. PubMed ID: 15950424
[TBL] [Abstract][Full Text] [Related]
34. Structural study of polymorphs and solvates of finasteride.
Othman A; Evans JS; Evans IR; Harris RK; Hodgkinson P
J Pharm Sci; 2007 May; 96(5):1380-97. PubMed ID: 17455354
[TBL] [Abstract][Full Text] [Related]
35. Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal.
Grossjohann C; Eccles KS; Maguire AR; Lawrence SE; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2012 Jan; 422(1-2):24-32. PubMed ID: 22020274
[TBL] [Abstract][Full Text] [Related]
36. Solid-state characterization and transformation of various creatine phosphate sodium hydrates.
Xu Y; Jiang L; Huang Y; Wang JR; Mei X
J Pharm Sci; 2014 Nov; 103(11):3688-3695. PubMed ID: 25223726
[TBL] [Abstract][Full Text] [Related]
37. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
38. Solid-state supramolecular synthesis based on the N-H…O heterosynthon: an approach to solve the polymorphism problem in famotidine.
Russo MG; Brusau EV; Ellena J; Narda GE
J Pharm Sci; 2014 Nov; 103(11):3754-3763. PubMed ID: 25277273
[TBL] [Abstract][Full Text] [Related]
39. Crystal forms of naproxen.
Song JS; Sohn YT
Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
[TBL] [Abstract][Full Text] [Related]
40. Enforcing Ostwald's rule of stages: isolation of paracetamol forms III and II.
Burley JC; Duer MJ; Stein RS; Vrcelj RM
Eur J Pharm Sci; 2007 Aug; 31(5):271-6. PubMed ID: 17561383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
